Brighter and lighter days ahead

Sooma tDCS™ – accessible, safe, and effective brain stimulation treatment for depression and chronic pain. Easy solution for optimized patiet care and flows.

Sooma Depression Treatment

Effective care for depression made accessible

Depression is a worldwide public health problem which overwhelms millions of people across age groups and backgrounds – and most are still waiting in line to access care. Sooma tDCS™ is a pioneering, safe, and scientifically proven brain stimulation treatment for both in-clinic and at-home treatment of depression. It’s a seamless remote solution that enables delivering better mental health to more patients in less time.

Contact us

Don’t hesitate to contact us with any questions you might have about Sooma products, the technology, or our company.

Image and content

Treating depression where it happens

Sooma tDCS™ is a groundbreaking and proven effective brain stimulation treatment which is used by licensed clinicians around the world. Developed in cooperation with medical professionals and health tech engineers, Sooma tDCS™ is both noninvasive and drug-free, and can be used either as a first-line of treatment or to bring additive effects to other forms of treatment. With regular daily use, most patients experience relief in their symptoms already after the first three weeks.

FAQ section lorem ipsum

Mauris sed libero. Suspendisse facilisis nulla in lacinia laoreet, lorem velit accumsan velit vel mattis libero nisl et sem. Proin interdum maecenas massa turpis sagittis in, interdum non lobortis vitae massa. Quisque purus lectus, posuere eget imperdiet nec sodales id arcu. Vestibulum elit pede dictum eu, viverra non tincidunt eu ligula.

Mauris sed libero. Suspendisse facilisis nulla in lacinia laoreet, lorem velit accumsan velit vel mattis libero nisl et sem. Proin interdum maecenas massa turpis sagittis in, interdum non lobortis vitae massa. Quisque purus lectus, posuere eget imperdiet nec sodales id arcu. Vestibulum elit pede dictum eu, viverra non tincidunt eu ligula.

Mauris sed libero. Suspendisse facilisis nulla in lacinia laoreet, lorem velit accumsan velit vel mattis libero nisl et sem. Proin interdum maecenas massa turpis sagittis in, interdum non lobortis vitae massa. Quisque purus lectus, posuere eget imperdiet nec sodales id arcu. Vestibulum elit pede dictum eu, viverra non tincidunt eu ligula.

Mauris sed libero. Suspendisse facilisis nulla in lacinia laoreet, lorem velit accumsan velit vel mattis libero nisl et sem. Proin interdum maecenas massa turpis sagittis in, interdum non lobortis vitae massa. Quisque purus lectus, posuere eget imperdiet nec sodales id arcu. Vestibulum elit pede dictum eu, viverra non tincidunt eu ligula.

asd

asd

  • asd
  • asd

Care through a current

Sooma tDCS™ is based on transcranial direct current stimulation (tDCS), an innovative therapy that is back by decades of research. It works by way of a small portable medical device, which is used in 30-minute sessions to safely deliver a weak electrical current to the dorsolateral prefrontal cortex (DLPFC).

tDCS is a safe treatment method that is not associated with any serious adverse effects, as established in a safety review based on over 40,000 stimulation sessions. To ensure appropriate usage as well as continuous progress and health monitoring, Sooma tDCS is always prescribed by a medical professional.

Icon list inside image and content

What is Sooma tDCS™?

Sooma tDCS™ combines pioneering brain stimulation technology with remote protocol management in one easy-to-use system for scalable treatment of depression and chronic pain.

Delivered through a portable device, the treatment utilizes transcranial direct current stimulation (tDCS) to relieve symptoms, with online treatment monitoring and adjustments for quick data-driven clinical decisions. It’s noninvasive, drug-free, and proven effective.

Clinical response typically within the first 3 weeks
without systemic side effects

Safe, effective, and affordable care
through low-cost equipment

Increased patient flows and shorter queues
via optimized resources and remote care

Easy adoption and onboarding
with simple treatment protocols and user training

Accordion

Mauris sed libero. Suspendisse facilisis nulla in lacinia laoreet, lorem velit accumsan velit vel mattis libero nisl et sem. Proin interdum maecenas massa turpis sagittis in, interdum non lobortis vitae massa. Quisque purus lectus, posuere eget imperdiet nec sodales id arcu. Vestibulum elit pede dictum eu, viverra non tincidunt eu ligula.

Mauris sed libero. Suspendisse facilisis nulla in lacinia laoreet, lorem velit accumsan velit vel mattis libero nisl et sem. Proin interdum maecenas massa turpis sagittis in, interdum non lobortis vitae massa. Quisque purus lectus, posuere eget imperdiet nec sodales id arcu. Vestibulum elit pede dictum eu, viverra non tincidunt eu ligula.

Mauris sed libero. Suspendisse facilisis nulla in lacinia laoreet, lorem velit accumsan velit vel mattis libero nisl et sem. Proin interdum maecenas massa turpis sagittis in, interdum non lobortis vitae massa. Quisque purus lectus, posuere eget imperdiet nec sodales id arcu. Vestibulum elit pede dictum eu, viverra non tincidunt eu ligula.

Mauris sed libero. Suspendisse facilisis nulla in lacinia laoreet, lorem velit accumsan velit vel mattis libero nisl et sem. Proin interdum maecenas massa turpis sagittis in, interdum non lobortis vitae massa. Quisque purus lectus, posuere eget imperdiet nec sodales id arcu. Vestibulum elit pede dictum eu, viverra non tincidunt eu ligula.

Map

Sooma tDCS™ clinics worldwide

Sooma tDCS™ treatment is available in more than 35 countries across four continents.

Sooma subsidiaries
Distributors

Quote with author

“Normal quote without author text-510”

“Normal quote without author”

“Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.”

Dr. Joh Doe

Doctor

“Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.”

Dr. Joh Doe

Doctor

Quote carousel group

Carousel group

Background boxes

Brochure for Patients

Quick Start Guide

asd

Background boxes after image and content

Add from block list patterns tab

Modern-day health care – in clinic or at home

Specifically designed for both in-clinic and at-home treatment, Sooma pairs tDCS with an easy-to-use secure system for informed treatment decisions and remote care.

The Sooma Clinician Portal allows customizing and tracking patient protocols via treatment logs, patient-reported outcomes, and dosage reports, while patients are guided through each session by the Sooma App.

The system communicates seamlessly with the Sooma device for easy patient-administered treatment sessions and comes with built-in adherence and monitoring capabilities – for cull clinician control.

Sooma Clinician Portal

Apple iOS application

Android application

Title and content

A short history of Sooma

Sooma Medical (Sooma Oy) is a Finnish medical device manufacturer established in 2013. With headquarters in Helsinki, Finland, we work at the core of medical research and technology to deliver effective treatment solutions for psychiatric and neurophysiological conditions that affect and inhibit millions of people all over the world.

Grounded in science, our solutions are developed in close cooperation with leading experts in psychiatry and clinical neurophysiology – as they have been from day one. All Sooma tDCS medical devices are manufactured in Finland in accordance with the ISO 13485 standard for Quality Management Systems for Medical Devices, ensuring the highest possible quality for clinicians and patients alike.

Our first solution was launched in 2014 with the debut of Sooma tDCS, the first generation of our brain stimulation treatment for Major Depressive Disorder. In 2017, our product portfolio expanded further to pain management as Sooma tDCS was approved for the treatment for fibromyalgia, chronic neuropathic pain, and other long-term pain conditions.

Today, we collaborate with more than 150 clinics, universities, and hospitals worldwide to provide them with a state-of-the-art neuromodulation devices for both research purposes and patient care. We are proud to be able to say that, since 2013, Sooma treatments have helped more than 20,000 patients find relief in more than 30 countries, with more than 100,000 treatment sessions successfully administered.

Logowall

Sooma tDCS™ treatment is available in more than 35 countries across four continents.

Centered numbers

2014

Launch of Sooma Depression Treatment and Sooma tDCS

2014

Class Ila CE marking (Depression)

2015

Malaysian Medical Device Authority (MDA) approval

2016

Australian TGA (Therapeutic Goods Administration) approval

2016

Health Canada (Chronic Pain Class III) approval

2017

Launch of Sooma Pain Management for Chronic Pain

2017

Singapre HSA (Health Science Authority) approval

2017

CE marking (Chronic Pain)

2017

Turkey (Depression)

2018

Mexican COFEPRIS (Federal Commission for Protection Against Health Risks) approval

2019

Indonesia (Depression)

Centered icons

(When adding a new item, you need to replace heading block to image block manually)

High-quality care with low-threshold access

Relieving symptoms – without generating new ones

Safe and effective treatment without fear of dependency

Better quality of life for everyone, every day, everywhere

Better quality of life for everyone, every day, everywhere

Better quality of life for everyone, every day, everywhere

Centered icons and titles

(When adding a new item, you need to add image block manually)

Faster clinical response

Decreased symptoms for most patients in just three weeks

Increased patient flows

Increased patient flows

Safe, effective, and affordable

Access to safe, effective and noninvasive care through low-cost equipment

Easy adoption

Simple treatment protocols with easily absorbed user materials and training.

Persons

Tuomas Neuvonen

Chief Executive Officer

first.last@soomamedical.com

Mika Nikander

Chief Operations Officer

first.last@soomamedical.com

Peter Hilgert

Chief Commercial Officer

first.last@soomamedical.com

Maria Kivistö

R&D

first.last@soomamedical.com

Anne Panhelainen

Clinical Process

first.last@soomamedical.com

Jouni Karkinen

Quality Assurance & Regulatory Affair

first.last@soomamedical.com

Ville Andsten

Sales

first.last@soomamedical.com

Seppo Nevalainen

Sales

first.last@soomamedical.com

Teemu Niemi

Chemical Plant

first.last@soomamedical.com

Neil Lunka

Marketing

first.last@soomamedical.com

Onni Pakkala

Customer Success

first.last@soomamedical.com

Johannes Österberg

Supply Chain

first.last@soomamedical.com

Naina Soni

Software Development

first.last@soomamedical.com

Jani Piippo

Software Development

first.last@soomamedical.com

Ahasan Hasan

Logistics

first.last@soomamedical.com

Vasilisa Tapaila

Chemical Laboratory Technician

first.last@soomamedical.com

Emma Haantio

Chemical Laboratory Technician

first.last@soomamedical.com

Olli Suopajärvi

Laboratory Assistant

first.last@soomamedical.com

asd